Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume.
Takahira KunoKenji TamuraNobutaka ShimizuHideo FukuharaSatoshi FukataShingo AshidaTakashi KarashimaHirofumi SatakeKohji SawadaIchiro YamasakiFumito KomatsuHajime KuroiwaMotoaki SaitoKeiji InouePublished in: Research and reports in urology (2023)
Vibegron 50 mg once daily significantly improved OABSS and OAB-q SF even in patients ≥80 years old. Notably, switching from mirabegron to vibegron resulted in significant improvements to residual urine volume.